Related Experiment Video
Updated: Aug 30, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
Decreasing IRS-2 expression in pancreatic beta-cells (INS-1) promotes apoptosis, which can be compensated for by
Melissa K Lingohr1, Lorna M Dickson, Christian E Wrede
1Pacific Northwest Research Institute, 720 Broadway, Seattle, WA 98122, USA.
Abstract:
IRS-2 plays a pivotal role in the control of pancreatic beta-cell growth. Here, the effect of altering IRS-2 expression levels in the pancreatic beta-cell line, INS-1, was examined. Adenoviral-mediated increased in IRS-2 protein levels protected against fatty acid (FFA)-induced apoptosis, associated with increased activation of PKB and decreased levels of activated caspase-9. Conversely, decreasing endogenous IRS-2 in INS-1 cells, using adenoviral-mediated expression of IRS-2 antisense, caused a three-fold increase in baseline apoptosis that was further enhanced in the presence of FFA. This was associated with decreased activation of PKB and increased caspase-9 activation. Although IRS-4 is not normally expressed in beta-cells, it was found that adenoviral-mediated introduction of IRS-4 into INS-1 cells enhanced glucose/IGF-1 induced mitogenesis, and protected against FFA-induced apoptosis, similarly to IRS-2. Moreover, expression of IRS-4 in INS-1 cells depleted of IRS-2 levels by IRS-2 antisense, was able to compensate for the lack of IRS-2 and reduce apoptosis in these cells back to normal. Thus, in beta-cells IRS-4 and -2 have similar biological functions. Also, this study further emphasizes the importance of IRS-2 signaling in control of beta-cell survival.
Insights
Insulin receptor substrate-2 (IRS-2) is crucial for pancreatic beta-cell survival. Upregulating IRS-2 or introducing IRS-4 protects beta-cells from apoptosis, while reducing IRS-2 increases cell death.
Area of Science:
- Molecular biology
- Cell biology
- Endocrinology
Background:
- Insulin receptor substrate-2 (IRS-2) is vital for pancreatic beta-cell proliferation and survival.
- Understanding IRS-2's role is critical for addressing beta-cell dysfunction in diseases like diabetes.
Purpose of the Study:
- To investigate the impact of altered IRS-2 expression on pancreatic beta-cell apoptosis.
- To explore the potential compensatory role of IRS-4 in beta-cells.
Main Methods:
- Utilized INS-1 pancreatic beta-cell line.
- Employed adenoviral vectors for manipulating IRS-2 and IRS-4 expression.
- Assessed apoptosis, protein levels (IRS-2, PKB), and caspase-9 activation.
Main Results:
- Increased IRS-2 protected against fatty acid-induced apoptosis by activating PKB and inhibiting caspase-9.
- Decreased IRS-2 significantly increased baseline and fatty acid-induced apoptosis.
- IRS-4 mimicked IRS-2's protective effects and compensated for IRS-2 depletion.
Conclusions:
- IRS-2 signaling is essential for beta-cell survival.
- IRS-4 exhibits similar biological functions to IRS-2 in beta-cells and can compensate for its absence.
- These findings highlight potential therapeutic targets for beta-cell protection.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin Secretory Vesicles
Regulation of the Unfolded Protein Response
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
